COMMUNITY HEALTH SYSTEMS INC
CYHNYSE
$3.30
↓ -2.4%Jul 17 close · end-of-day
Price
1Y↓ -9.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$443.6M
Enterprise Value
$9.9B
P/E
1.0
P/S
0.0
P/B
—
EV/EBITDA
5.1
PEG
0.0
FCF Yield
-45.1%
Dividend Yield
—
Revenue (TTM)
$12.3B
Net Income (TTM)
$464.0M
Free Cash Flow (TTM)
-$200.0M
Gross Margin
—
Operating Margin
12.1%
Net Margin
3.8%
ROE
-31.9%
ROIC
16.1%
Debt / Equity
-7.0
Net Cash
-$9.4B
Return 1Y
-9.3%
Company profile
Community Health Systems, Inc. owns, leases, and operates hospitals in the United States. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
- CEO
- Tim L. Hingtgen
- Sector
- Services
- Industry
- Healthcare
- Employees
- 66,000
- Headquarters
- Tennessee
- Website
- chs.net
Management & directors
- Rice David V.EVP-Clinical Operations & CMO
- Hammons Kevin JCEO
- Johnson Jason KEVP & CFO
- Pitt Justin DPres,Chief Legal&Admin Officer
- Posey Phillip A.SVP & CAO
- Stockton Kevin AEVP, Operations & Development
Roles derived from SEC Form 4 filings.
Earnings
CYH Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$3.0B↓ -6.1%
Diluted EPS-$0.43↑ +330.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $11.8B | $12.4B | $12.2B | $12.5B | $12.6B | $12.5B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $1.1B | $1.4B | $821.0M | $957.0M | $542.0M | $1.5B |
| Net income | $511.0M | $230.0M | $46.0M | -$133.0M | -$516.0M | $509.0M |
| Diluted EPS | $4.39 | $1.76 | $0.35 | -$1.02 | -$3.90 | $3.77 |
| Operating cash flow | $2.2B | -$131.0M | $300.0M | $210.0M | $480.0M | $543.0M |
| Free cash flow | $1.7B | -$600.0M | -$115.0M | -$257.0M | $120.0M | $208.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 9.6% | 11.3% | 6.7% | 7.7% | 4.3% | 11.9% |
| Net margin | 4.3% | 1.9% | 0.4% | -1.1% | -4.1% | 4.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $3.1B | $3.3B | $3.2B | $3.1B | $3.1B | $3.1B | $3.0B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $238.0M | -$205.0M | $278.0M | $284.0M | $512.0M | $243.0M | $449.0M | $281.0M |
| Net income | -$13.0M | -$391.0M | -$71.0M | -$13.0M | $282.0M | $130.0M | $110.0M | -$58.0M |
| Diluted EPS | -$0.10 | -$2.95 | -$0.53 | -$0.10 | $2.09 | $0.96 | $0.82 | -$0.43 |
| Operating cash flow | $101.0M | $67.0M | $216.0M | $120.0M | $88.0M | $69.0M | $266.0M | -$297.0M |
| Free cash flow | $13.0M | -$3.0M | $107.0M | $35.0M | -$3.0M | $4.0M | $172.0M | -$373.0M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 7.6% | -6.6% | 8.5% | 9.0% | 16.3% | 7.9% | 14.5% | 9.5% |
| Net margin | -0.4% | -12.7% | -2.2% | -0.4% | 9.0% | 4.2% | 3.5% | -2.0% |
Company news
Jul 16, 2026
Jul 8, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Krishnan K Ranga | Option exercise | 13,930 | $0.00 | $0.00 | filing |
| 2026-06-01 | Rice David V.· EVP-Clinical Operations & CMO | Award | 30,000 | $0.00 | $0.00 | filing |
| 2026-04-22 | Krishnan K Ranga | Option exercise | 46,950 | $0.00 | $0.00 | filing |
| 2026-03-02 | SMITH WAYNE T | Gift | 19,400 | $0.00 | $0.00 | filing |
| 2026-03-01 | HAMMONS KEVIN J· CEO | Tax withholding | 96,896 | $3.46 | $335,260.16 | filing |
| 2026-03-01 | STOCKTON KEVIN A· EVP, Operations & Development | Tax withholding | 35,573 | $3.46 | $123,082.58 | filing |
| 2026-03-01 | Pitt Justin D· Pres,Chief Legal&Admin Officer | Tax withholding | 24,922 | $3.46 | $86,230.12 | filing |
| 2026-03-01 | Johnson Jason K· EVP & CFO | Tax withholding | 23,610 | $3.46 | $81,690.60 | filing |
| 2026-03-01 | Posey Phillip A.· SVP & CAO | Tax withholding | 1,188 | $3.46 | $4,110.48 | filing |
| 2026-03-01 | HAMMONS KEVIN J· CEO | Award | 200,000 | $0.00 | $0.00 | filing |
| 2026-03-01 | Williams Hubert James | Option exercise | 9,756 | $0.00 | $0.00 | filing |
| 2026-03-01 | Williams Hubert James | Option exercise | 20,906 | $0.00 | $0.00 | filing |
| 2026-03-01 | Williams Hubert James | Option exercise | 19,933 | $0.00 | $0.00 | filing |
| 2026-03-01 | Hirsch Elizabeth T | Option exercise | 9,756 | $0.00 | $0.00 | filing |
| 2026-03-01 | Hirsch Elizabeth T | Option exercise | 20,906 | $0.00 | $0.00 | filing |
| 2026-03-01 | Hirsch Elizabeth T | Option exercise | 19,933 | $0.00 | $0.00 | filing |
| 2026-03-01 | FRY JOHN A | Option exercise | 9,756 | $0.00 | $0.00 | filing |
| 2026-03-01 | FRY JOHN A | Option exercise | 20,906 | $0.00 | $0.00 | filing |
| 2026-03-01 | FRY JOHN A | Option exercise | 19,933 | $0.00 | $0.00 | filing |
| 2026-03-01 | Ely James S. III | Option exercise | 9,756 | $0.00 | $0.00 | filing |
| 2026-03-01 | Ely James S. III | Option exercise | 20,906 | $0.00 | $0.00 | filing |
| 2026-03-01 | Ely James S. III | Option exercise | 19,933 | $0.00 | $0.00 | filing |
| 2026-03-01 | DINKINS MICHAEL | Option exercise | 9,756 | $0.00 | $0.00 | filing |
| 2026-03-01 | DINKINS MICHAEL | Option exercise | 20,906 | $0.00 | $0.00 | filing |
| 2026-03-01 | CLERICO JOHN A | Option exercise | 9,756 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.